Objective: To assess the sensitivity, specificity, and feasibility of a new chemiluminescence immunoassay (CLIA) in the diagnosis of syphilis. Methods: At first, a retrospective study was conducted, using 135 documented cases of syphilis and 30 potentially interfering samples and 80 normal sera. A prospective study was also performed by testing 2, 071 unselected samples for routine screening for syphilis. CLIA was compared with a nontreponemal test (TRUST) and a treponemal test (TPPA). Results: There was an agreement of 100% between CLIA and TPPA in the respective study. The percentage of agreement among the 245 sera tested was 100.0%. Compared with TPPA, the specificity of CLIA was 99.9% (1817/1819), the sensitivity of CLIA was 100.0% (244/244) in the prospective study. CLIA showed 99.5% agreement with TPPA by testing 2, 071 unselected samples. And CLIA seemed to be more sensitive than TPPA in detecting the samples of primary syphilis. Conclusions: CLIA is easy to perform and the indicator results are objective and unequivocal. It may be suitable for large-scale screening as a treponemal test substituted for TPPA. © I. Holzapfel Publishers 2010.
CITATION STYLE
Mo, X., Jin, Y., Yang, Y., Hu, W., & Gu, W. (2010). Evaluation of a new chemiluminescence immunoassay for diagnosis of syphilis. European Journal of Medical Research, 15(2), 66–69. https://doi.org/10.1186/2047-783x-15-2-66
Mendeley helps you to discover research relevant for your work.